Description
Currently under investigation for colorectal cancer (CRC), JS015 has shown promise in preclinical studies but lacks clinical data to support its use as a standard treatment option. Its exact role and efficacy in CRC remain undefined pending further research.
Mechanism of Action
JS015 is an investigational drug targeting a specific protein involved in cell proliferation and survival pathways, potentially inhibiting tumor growth.
Side Effects
No clinical data available; potential side effects are speculative and based on similar drugs targeting the same pathway.
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT06885385
Phase 2
Recruiting
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
China
Quick Info
| Category | Other Medications |
 EMA Status | Experimental |
 Spain Access | Not available |
| Clinical Trials | 1 |
Related Medications
Uracil
Other Medications
768 trials
Leucovorin
Other Medications
627 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.